WO1998002240A1 - Preservation by foam formation - Google Patents

Preservation by foam formation Download PDF

Info

Publication number
WO1998002240A1
WO1998002240A1 PCT/US1997/012156 US9712156W WO9802240A1 WO 1998002240 A1 WO1998002240 A1 WO 1998002240A1 US 9712156 W US9712156 W US 9712156W WO 9802240 A1 WO9802240 A1 WO 9802240A1
Authority
WO
WIPO (PCT)
Prior art keywords
foam
drying
biologically active
vacuum
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/012156
Other languages
English (en)
French (fr)
Other versions
WO1998002240B1 (en
Inventor
Victor Bronshtein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Preservation Technologies Inc
Original Assignee
Universal Preservation Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26695104&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1998002240(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to HU9903917A priority Critical patent/HUP9903917A3/hu
Application filed by Universal Preservation Technologies Inc filed Critical Universal Preservation Technologies Inc
Priority to EA199900268A priority patent/EA001138B1/ru
Priority to DE0914202T priority patent/DE914202T1/de
Priority to EP97933415A priority patent/EP0914202A4/en
Priority to NZ333738A priority patent/NZ333738A/xx
Priority to JP10506201A priority patent/JP2000515856A/ja
Priority to AU36606/97A priority patent/AU714328B2/en
Priority to BR9711808-7A priority patent/BR9711808A/pt
Priority to IL12797197A priority patent/IL127971A/en
Publication of WO1998002240A1 publication Critical patent/WO1998002240A1/en
Publication of WO1998002240B1 publication Critical patent/WO1998002240B1/en
Priority to NO990158A priority patent/NO990158D0/no
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Definitions

  • the invention relates to methods for preserving sensitive biologically active solutes and suspensions, emulsions and dispersions of, for example, enzymes, proteins, viruses, serums, vaccines, liposomes and cell suspensions .
  • the present invention is a method of preserving sensitive biological suspensions and solutions by forming stable foams from fluid materials to be dried, as an aid both to the drying of one or more biologically active substrates in the fluid and as an aid in preparing an easily soluble dried product suitable for further commercial use.
  • the stable foams are formed by partially removing water in the biologically active sample to form a viscous liquid and by further subjecting the reduced liquid to vacuum to cause it to "boil" during further drying at temperatures substantially lower than 100 degrees C.
  • the present invention is a method of preserving sensitive biological dispersions, suspensions, emulsions and solutions by forming stable foams from fluid materials to be dried, as an aid both to the drying of one or more biologically active substrates in the fluid and as an aid in preparing an easily divisible dried product suitable for further commercial use.
  • the stable foams are formed by partially removing the water to form a viscous liquid and by further subjecting the reduced liquid to vacuum, to cause it to "boil" during further drying at temperatures substantially lower than 100 degrees C.
  • reduced pressure is applied to viscous solutions or suspensions of biologically active materials to cause the solutions or suspensions to foam during boiling, and during the foaming process further solvent removal causes the ultimate production of a stable open-cell or closed-cell foam.
  • foams are easily divisible by cutting, milling or other dividing techniques, and the foaming action itself enhances water removal by maximizing liquid surface area available for evaporation.
  • the solvent fraction of the materials to be dried will be aqueous, however, it should be understood that the present method may be applied to solutions and suspensions of various types including those containing nonaqueous solvents or mixture of such solvents .
  • the inventive apparatus is a novel combination of a vacuum pump with a temperature controlled desiccator device.
  • Optional features of such a combination include sensors for temperature measurement and heat flow control, microprocessors for calculating other process parameters based on data collected from these and other sensors and etc.
  • Such a device allows implementation of a novel two- dimensional vacuum and temperature protocol for drying.
  • the foam forming process includes two steps: (a) an intensive dehydration of the solution or dispersion containing the biologically active agent by boiling under vacuum, to form a stable, non-collapsing foam and (b) subsequent secondary drying of the foams, to the extent that the foams are stable and do not collapse during storage.
  • the invention provides a scalable method for preserving sensitive biologically active materials (proteins, enzymes, serums, vaccines, viruses, liposomes and cell suspensions) with a uniquely engineered drying method. Using this method, it is possible to rehydrate the samples with water or aqueous solutions to reverse the process to the initial biological activity. The method may be applied for the preservation of pharmaceutical, fluid or virtually any other biologically active products or solutes.
  • foams are a kinetic process and depends on the rate of temperature and vacuum changes during formation of the foam as well as the initial concentration and composition of the solution or dispersion containing the biologically active substance. Stability of the foams may be further enhanced by the addition of surfactants or other synthetic or biological polymers as long as those additives do not interfere with the biological activity of the solute intended for conversion to dry form. Secondary drying and optional cooling of the formed and initially dry foams may be conducted to assure stability of the foam during storage. Cooling may be used to convert the foamed material to the glass state. Foams prepared according to the present invention may be stored whole or subdivided or milled, and when they are to be used need only be rehydrated in order to restore their original biologic activity.
  • Aqueous 50% glycerol isocitrate dehydrogenase solution from Sigma Chemical Co. containing 59.4 units of activity per ml. was dialyzed for 5 hours in 0.1 M TRIS HC1 buffer (pH 7.4).
  • the activity decrease was associated with decrease in the enzyme concentration because of dilution during the dialysis.
  • the samples were rehydrated with 500 microliters water. Rehydration of the samples containing dry foams was an easy process that was completed within several seconds. Reconstituted sample was assayed for activity by assaying ability to reduce NADP, measured spectrophotometrically at 340 nm.
  • the activity was 2.6 +/- 0.2 units/ml. which means there was no loss of activity during drying and subsequent storage at room temperature .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Drying Of Solid Materials (AREA)
  • Colloid Chemistry (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
PCT/US1997/012156 1996-07-15 1997-07-14 Preservation by foam formation Ceased WO1998002240A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU36606/97A AU714328B2 (en) 1996-07-15 1997-07-14 Preservation by foam formation
JP10506201A JP2000515856A (ja) 1996-07-15 1997-07-14 泡沫形成による保存
EA199900268A EA001138B1 (ru) 1996-07-15 1997-07-14 Защита пенообразованием
DE0914202T DE914202T1 (de) 1996-07-15 1997-07-14 Konservierung durch schaumformung
EP97933415A EP0914202A4 (en) 1996-07-15 1997-07-14 CONSERVATION THROUGH FOAM FORMING
NZ333738A NZ333738A (en) 1996-07-15 1997-07-14 Shelf preservation of biological active material by forming a mechanically stable foam thereof
BR9711808-7A BR9711808A (pt) 1996-07-15 1997-07-14 Preservação através de formação de espuma.
HU9903917A HUP9903917A3 (en) 1996-07-15 1997-07-14 Preservation by foam formation
IL12797197A IL127971A (en) 1996-07-15 1997-07-14 Preservation by creating foam
NO990158A NO990158D0 (no) 1996-07-15 1999-01-14 Konservering ved skumdannelse

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2179696P 1996-07-15 1996-07-15
US60/021,796 1996-07-15
US08/785,473 1997-01-17
US08/785,473 US5766520A (en) 1996-07-15 1997-01-17 Preservation by foam formation

Publications (2)

Publication Number Publication Date
WO1998002240A1 true WO1998002240A1 (en) 1998-01-22
WO1998002240B1 WO1998002240B1 (en) 1998-03-05

Family

ID=26695104

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/012156 Ceased WO1998002240A1 (en) 1996-07-15 1997-07-14 Preservation by foam formation

Country Status (18)

Country Link
US (1) US5766520A (enExample)
EP (1) EP0914202A4 (enExample)
JP (1) JP2000515856A (enExample)
KR (1) KR100457748B1 (enExample)
CN (1) CN1116104C (enExample)
AU (1) AU714328B2 (enExample)
BR (1) BR9711808A (enExample)
CA (1) CA2260233A1 (enExample)
CZ (1) CZ7999A3 (enExample)
DE (1) DE914202T1 (enExample)
EA (1) EA001138B1 (enExample)
HU (1) HUP9903917A3 (enExample)
IL (1) IL127971A (enExample)
NO (1) NO990158D0 (enExample)
NZ (1) NZ333738A (enExample)
PL (1) PL331174A1 (enExample)
TR (1) TR199900127T2 (enExample)
WO (1) WO1998002240A1 (enExample)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027071A1 (en) * 1997-11-26 1999-06-03 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
WO2000040696A1 (en) * 1999-01-05 2000-07-13 Universal Preservation Technologies, Inc. Preservation of sensitive biological materials at ambient temperatures by vitrification
WO2000066710A3 (en) * 1999-05-04 2001-02-08 Eric Edward Worrall Method for the preservation of viruses and mycoplasma
WO2001037804A3 (en) * 1999-11-22 2001-11-22 Universal Preservation Technologies Inc Preservation and formulation of bioactive materials
WO2002000201A3 (en) * 2000-06-27 2002-04-18 Hoffmann La Roche Method for preparing a composition
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
US7153472B1 (en) 2000-11-22 2006-12-26 Quadrant Drug Delivery Limited Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
EP1494651A4 (en) * 2002-04-11 2010-10-13 Medimmune Vaccines Inc PRESERVATION OF BIOACTIVE MATERIALS WITH FREEZZED FOAM
US20230357807A1 (en) * 2020-07-27 2023-11-09 Karlsruher Institut Fuer Technologie Catalytically active protein foams, and method for producing same

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332105T2 (de) * 1992-09-29 2003-03-06 Inhale Therapeutic Systems, San Carlos Pulmonale abgabe von aktiven fragmenten des parathormons
EP0748213B1 (en) 1994-03-07 2004-04-14 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
JPH10508744A (ja) 1994-09-22 1998-09-02 クオドラント ホールディングス ケンブリッジ リミテッド 運動競技の間の水分補給および栄養摂取の用途のための組成物ならびにその製造法
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
EP1144930A1 (en) 1999-01-05 2001-10-17 Universal Preservation Technologies, Inc. Vacuum control system for foam drying apparatus
CA2382061A1 (en) * 1999-08-19 2001-02-22 Victor Bronshtein Preservation of bacterial cells at ambient temperatures
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
WO2001094867A1 (en) 2000-06-07 2001-12-13 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials
US6872357B1 (en) * 2000-11-22 2005-03-29 Quadrant Drug Delivery Limited Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying
AU2002305461A1 (en) * 2001-05-07 2002-11-18 Universal Preservation Technologies, Inc. Preservation of competent cells at ambient temperatures
US6884866B2 (en) * 2001-10-19 2005-04-26 Avant Immunotherapeutics, Inc. Bulk drying and the effects of inducing bubble nucleation
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
DK1556477T3 (en) * 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20050100636A1 (en) * 2003-11-10 2005-05-12 Megan Botteri [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1750760B1 (en) 2004-06-02 2017-06-28 Universal Stabilization Technologies, Inc. Preservation by vaporization
US9744227B2 (en) 2004-06-02 2017-08-29 Universal Stabilization Technologies, Inc. Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof
JP2007277094A (ja) * 2004-06-29 2007-10-25 Chemo Sero Therapeut Res Inst 改変ダニ主要アレルゲン含有医薬組成物
CN1993411B (zh) * 2004-07-30 2010-11-24 不列颠哥伦比亚大学 水状胶体泡沫的制备方法
ATE512211T1 (de) * 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
ES2607988T3 (es) * 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
US9453675B2 (en) * 2006-02-10 2016-09-27 Sp Industries, Inc. Method of inducing nucleation of a material
CN103933612B (zh) 2006-10-27 2016-06-22 爱德华兹生命科学公司 用于外科植入的生物组织
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
EP2148923B1 (en) * 2007-05-18 2012-08-22 MedImmune, LLC Preservation of bioactive materials by freeze dried foam
US9101691B2 (en) * 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
KR101540920B1 (ko) 2007-07-26 2015-08-03 사노피 파스퇴르 리미티드 항원-애주번트 조성물 및 방법
CA2699120C (en) * 2007-09-13 2014-07-08 Enwave Corporation Apparatus and method for dehydrating biological materials
US8357387B2 (en) * 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2329005A4 (en) 2008-09-12 2011-10-12 Enwave Corp DEVICE AND METHOD FOR DEHYDRATING BIOLOGICAL MATERIAL WITH FREEZERS AND MICROWAVES
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
KR101799983B1 (ko) 2009-05-26 2017-12-20 어드밴스드 바이오뉴트리션 코프. 생물학적 활성 미생물 및/또는 생활성 물질을 포함하는 안정한 건식분말 조성물 및 제조 방법
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2475393A4 (en) * 2009-09-14 2013-08-21 Vu Truong-Le FORMULATION FOR THE ROOM TEMPERATURE STABILIZATION OF A WEAKED LIVING BACTERIAL VACCINE
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
CA2794121C (en) 2010-03-23 2016-10-11 Edwards Lifesciences Corporation Methods of conditioning sheet bioprosthetic tissue
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
CA2794135C (en) 2010-06-17 2018-01-02 Edwards Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
ES2856187T3 (es) 2013-05-31 2021-09-27 Victor Bronshtein Composiciones poliméricas que contienen productos biofarmacéuticos estables a temperatura ambiente y métodos para la formulación de las mismas
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
ES2978111T3 (es) 2015-06-25 2024-09-05 Native Microbials Inc Métodos, aparatos y sistemas para analizar cepas de microorganismos de comunidades heterogéneas complejas, predecir e identificar relaciones funcionales e interacciones de las mismas, y seleccionar y sintetizar conjuntos microbianos basados en las mismas
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
BR112018001784B1 (pt) 2015-07-29 2022-05-10 Advanced Bionutrition Corp Composições probióticas secas estáveis para usos dietéticos especiais, seu método de preparação e método de preparação de uma fórmula para bebês
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
US10617134B2 (en) 2016-04-15 2020-04-14 Ascus Biosciences, Inc. Methods for improving agricultural production of fowl by administration of microbial compositions or purified strains thereof
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
EP3562954A1 (en) 2016-12-28 2019-11-06 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
JP2020503048A (ja) 2016-12-28 2020-01-30 アスカス バイオサイエンシーズ， インコーポレイテッド トレーサー分析論による複雑な不均一コミュニティの微生物株の解析、その機能的関連性及び相互作用の決定、ならびに微生物アンサンブル（投与される微生物アンサンブル及び接種される微生物アンサンブルを含む）の合成、のための方法、装置、及びシステム
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
US10617756B2 (en) 2017-01-05 2020-04-14 Shimojani, LLC Drug regimen for treatment of cerebral ischemia
WO2018201154A1 (en) * 2017-04-28 2018-11-01 Universal Stabilization Technologies, Inc. Antigenic thermostable polio vaccines & related methods
EP3631062B1 (en) 2017-05-31 2025-08-27 Edwards Lifesciences Corporation Collagen fibers and articles formed therefrom
MX2020003992A (es) 2017-10-18 2020-08-13 Native Microbials Inc Aumento de la produccion de aves de corral mediante la administracion de un bioensamblaje sintetico de microbios o cepas purificadas de los mismos.
EP3743124B1 (en) 2018-01-23 2024-05-08 Edwards Lifesciences Corporation Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
JP7138336B2 (ja) * 2018-06-29 2022-09-16 国立大学法人九州工業大学 生体由来の水溶性高分子乾燥品の製造方法及びその製造装置
CA3116158A1 (en) 2018-11-01 2020-05-07 Edwards Lifesciences Corporation Transcatheter pulmonic regenerative valve
WO2021118964A1 (en) 2019-12-09 2021-06-17 Edwards Lifesciences Corporation Bioprosthetic tissue preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271881A (en) * 1987-09-28 1993-12-21 Redding Bruce K Apparatus and method for making microcapsules
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5565318A (en) * 1994-09-02 1996-10-15 Pharmacia Biotech, Inc. Room temperature stable reagent semi-spheres

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000196A1 (en) * 1985-07-09 1987-01-15 Quadrant Bioresources Limited Protection of proteins and the like
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
US5200399A (en) * 1990-09-14 1993-04-06 Boyce Thompson Institute For Plant Research, Inc. Method of protecting biological materials from destructive reactions in the dry state
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
ATE239451T1 (de) * 1995-06-07 2003-05-15 Elan Drug Delivery Ltd Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271881A (en) * 1987-09-28 1993-12-21 Redding Bruce K Apparatus and method for making microcapsules
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5565318A (en) * 1994-09-02 1996-10-15 Pharmacia Biotech, Inc. Room temperature stable reagent semi-spheres

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027071A1 (en) * 1997-11-26 1999-06-03 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6306345B1 (en) 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
WO2000040696A1 (en) * 1999-01-05 2000-07-13 Universal Preservation Technologies, Inc. Preservation of sensitive biological materials at ambient temperatures by vitrification
WO2000066710A3 (en) * 1999-05-04 2001-02-08 Eric Edward Worrall Method for the preservation of viruses and mycoplasma
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
WO2001037804A3 (en) * 1999-11-22 2001-11-22 Universal Preservation Technologies Inc Preservation and formulation of bioactive materials
US6534087B2 (en) 2000-06-27 2003-03-18 Hoffmann-La Roche Inc. Process for preparing a pharmaceutical composition
WO2002000201A3 (en) * 2000-06-27 2002-04-18 Hoffmann La Roche Method for preparing a composition
US7074431B2 (en) * 2000-06-27 2006-07-11 Hoffmann-La Roche Inc. Process for preparing a pharmaceutical composition
HRP20021009B1 (hr) * 2000-06-27 2011-07-31 F. Hoffmann - La Roche Ag Postupak za pripremu pripravka
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
US7153472B1 (en) 2000-11-22 2006-12-26 Quadrant Drug Delivery Limited Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
EP1494651A4 (en) * 2002-04-11 2010-10-13 Medimmune Vaccines Inc PRESERVATION OF BIOACTIVE MATERIALS WITH FREEZZED FOAM
US8067017B2 (en) 2002-04-11 2011-11-29 Medimmune, Llc Preservation of bioactive materials by freeze dried foam
US8343518B2 (en) 2002-04-11 2013-01-01 Medimmune, Llc Preservation of bioactive materials by freeze dried foam
EP2591771A1 (en) * 2002-04-11 2013-05-15 MedImmune, LLC Preservation of bioactive materials by freeze dried foam
US20230357807A1 (en) * 2020-07-27 2023-11-09 Karlsruher Institut Fuer Technologie Catalytically active protein foams, and method for producing same

Also Published As

Publication number Publication date
CN1116104C (zh) 2003-07-30
EP0914202A4 (en) 2004-09-01
IL127971A (en) 2001-09-13
CZ7999A3 (cs) 1999-11-17
NO990158L (no) 1999-01-14
EA001138B1 (ru) 2000-10-30
KR20000023779A (ko) 2000-04-25
AU3660697A (en) 1998-02-09
BR9711808A (pt) 2000-01-18
PL331174A1 (en) 1999-06-21
JP2000515856A (ja) 2000-11-28
DE914202T1 (de) 2000-02-17
TR199900127T2 (xx) 1999-04-21
US5766520A (en) 1998-06-16
IL127971A0 (en) 1999-11-30
AU714328B2 (en) 1999-12-23
EA199900268A1 (ru) 1999-10-28
CN1226842A (zh) 1999-08-25
EP0914202A1 (en) 1999-05-12
CA2260233A1 (en) 1998-01-22
HUP9903917A2 (hu) 2000-03-28
HUP9903917A3 (en) 2000-06-28
NZ333738A (en) 2000-09-29
KR100457748B1 (ko) 2004-11-17
NO990158D0 (no) 1999-01-14

Similar Documents

Publication Publication Date Title
US5766520A (en) Preservation by foam formation
US6509146B1 (en) Scalable long-term shelf preservation of sensitive biological solutions and suspensions
EP1032647B1 (en) Preservation of sensitive biological samples by vitrification
WO1998002240B1 (en) Preservation by foam formation
EP1750760B1 (en) Preservation by vaporization
Hahn-Hägerdal Water activity: a possible external regulator in biotechnical processes
US6872357B1 (en) Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying
US6653062B1 (en) Preservation and storage medium for biological materials
US20030022333A1 (en) Long-term shelf preservation by vitrification
CA2040815C (en) Enzyme stabilisation
AU2001268057A1 (en) Preservation and storage medium for biological materials
JPH02265984A (ja) 物質の貯蔵
CN115024310B (zh) 一种细胞冻干保存剂及其制备方法
EP1231837A2 (en) Preservation of sensitive biological material
Ekdawi‐Sever et al. Effects of annealing on freeze‐dried Lactobacillus acidophilus
CN1286725A (zh) 敏感性生物样品的玻化保质法
MXPA00005123A (en) Preservation of sensitive biological samples by vitrification
Salemink Cell and cell constituent freeze-drying: fundamentals and principles
Rapoporta et al. Anhydrobiosis in Yeast: Stabilization by Exogenous Lactose1

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97196422.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2260233

Country of ref document: CA

Ref document number: 2260233

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1999-79

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 333738

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/A/1999/000592

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1019997000253

Country of ref document: KR

Ref document number: 1999/00127

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 1997933415

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 199900268

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1997933415

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV1999-79

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019997000253

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1999-79

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 1019997000253

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1997933415

Country of ref document: EP